摘要
目的观察益赛普治疗强直性脊柱炎的疗效。方法选取本院33例强直性脊柱炎患者,使用益赛普治疗,对患者治疗前后的临床观察指标和实验室指标进行评估。结果治疗后患者的脊柱痛视觉模拟评分、病人总体评价(Patient Global Evaluation,PGA)视觉模拟评分、血沉以及C反应蛋白均有明显改善(P<0.05)。结论益赛普治疗强直性脊柱炎安全有效。
Objective To explore the efficacy of Entanercept in treatment of patients with ankylosing spondylitis. Methods Thirty-three patients with ankylosing spondylitis were treated by Entanercept,the clinical observation index and laboratory parameters were evaluated before and after treatment. Results The score of rachiodynia,score of PGA,erythrocyte sedimentation rate and C reactive protein were improved significantly after treatment(P<0.05). Conclusion The efficacy of entanercept in treatment of patients with ankylosing spondylitis is distinct and safe.
出处
《大医生》
2017年第6期8-8,29,共2页
Doctor
关键词
强直性脊柱炎
益赛普
疗效
ankylosing spondylitis
entanercept
efficacy